Home health stakeholders are hopeful a draft Medicaid integrity rule undergoing White House review will scrap a Biden-era direct pay requirement they argue stifles technological innovation and ...
The deadline for state Medicaid agencies to finalize their decision on whether to participate in the Trump administration’s model testing the ability of "most favored nation” pricing to bring down the ...
FDA on Wednesday (Oct. 14) launched a Rare Disease Framework Initiative that it says will reform the development of rare disease treatments by considering each disease’s specific patient population ...
Eli Lilly is moving forward with plans to ask FDA to approve its latest experimental weight-loss drug, retatrutide, as a biologic after the GLP-1 showed substantial weight loss in patients with ...
The Trump administration may press pause on new agents and brokers in healthcare.gov ahead of the plan year 2027 according to a notice titled “Private Health Insurance; New Agent/Broker Registrations ...
States report obligating less than half of the Rural Health Transformation Program funding CMS sent them this year, but the administration notes its first glimpse of RHTP spending is not a full view ...
Two measles-associated deaths in Pennsylvania are leading to a heated dispute between the state and federal government as HHS Secretary Robert F. Kennedy Jr. suggests measles may not have been the ...
Virginia Democratic Sen. Mark Warner Thursday introduced a wide-ranging health care package that calls for reversing the cuts to Medicaid, permanently funding the enhanced Affordable care Act tax ...
Two former GOP health care lawmakers are warning the White House that rising infectious disease rates coupled with the administration’s mixed messaging on vaccines are a “self-inflicted wound” that ...
Health policy stakeholders and former FDA officials are backing a group of bipartisan drug development reforms they say could boost domestic clinical research and expand patient access to treatments, ...
A new group of hospitals is rallying for the United States District Court for the District of Maine to once again block the government from implementing a pilot program that will replace upfront ...
FDA has formally asked the White House Office of Management and Budget (OMB) to approve an “interim access policy” that could create a temporary pathway for state-licensed pharmacies to compound ...